Eswar Krishnan

10.2k citations
110 papers · 8.5k · 2 hit papers · h-index 52

Impact in

  • Nephrology top 0.2%
    • Gout, Hyperuricemia, Uric Acid
  • Rheumatology top 0.2%
    • Rheumatoid Arthritis Research and Therapies
    • Spondyloarthritis Studies and Treatments
    • Systemic Lupus Erythematosus Research

Papers in

    • Gout, Hyperuricemia, Uric Acid 39
    • Rheumatoid Arthritis Research and Therapies 19
    • Systemic Lupus Erythematosus Research 4
    • Spondyloarthritis Studies and Treatments 3

Eswar Krishnan

109 papers receiving 8.2k citations

Eswar Krishnan's Hit Papers

A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial 2019 · 238 citations
2380+2+5Years since publication50100150200250

Peers

Eswar Krishnan
Comparison fields: 5 of 146
  • Nephrology 3k
  • Rheumatology 2k
  • Aging 48
  • Management Science and Operations Research 465
  • Pharmacology 405
Replace Kaleb D. Michaud with:
Kaleb D. Michaud United States
Annelies E. R. C. H. Boonen Netherlands
Jaap Fransen Netherlands
Debbie S. Gipson United States
Leslie R. Harrold United States
Till Uhlig Norway
Rieke Alten Germany
Corri Black United Kingdom
Dawei Xie United States
Harold E. Paulus United States
Eswar Krishnan relative to Kaleb D. Michaud United States Kaleb D. Michaud's profile →
Citations per field
00.5×5×10×14.1×
Kaleb D. Michaud · 1×
Citations per year

Countries citing papers authored by Eswar Krishnan

Since Specialization
Citations

This map shows the geographic impact of Eswar Krishnan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eswar Krishnan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eswar Krishnan more than expected).

Fields of papers citing papers by Eswar Krishnan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eswar Krishnan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eswar Krishnan. The network helps show where Eswar Krishnan may publish in the future.

Co-authors

The 25 scholars most cited alongside Eswar Krishnan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eswar Krishnan Line = papers co-authored together Eswar Krishnan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 110 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2006363
2 2012309
3 2005300
4
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial
Hit paper breakdown →
2018290
5 2008285
6
A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial
Hit paper breakdown →
2019238
7 2006236
8 2012226
9 2009216
10 2006215
11 2004181
12 2010178
13 2018178
14 2013170
15 2008156
16 2011154
17 2007151
18 2013142
19 2011138
20 2012134

About Eswar Krishnan

Eswar Krishnan is a scholar working on Nephrology, Rheumatology, Management Science and Operations Research, Pathology and Forensic Medicine and Economics and Econometrics, having authored 110 papers that have together received 8.5k indexed citations. Recurring topics across this work include Gout, Hyperuricemia, Uric Acid (39 papers), Rheumatoid Arthritis Research and Therapies (19 papers), Psychometric Methodologies and Testing (16 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers), Systemic Sclerosis and Related Diseases (6 papers), Systemic Lupus Erythematosus Research (4 papers), Physical Activity and Health (3 papers) and Spondyloarthritis Studies and Treatments (3 papers). The work is most often cited by research in Nephrology (3k citations), Rheumatology (2k citations), Aging (48 citations), Management Science and Operations Research (465 citations) and Pharmacology (405 citations). Eswar Krishnan has collaborated with scholars based in United States, Netherlands and Finland. Frequent co-authors include James F. Fries, H. Ralph Schumacher, Joshua F. Baker, Chian Kent Kwoh, Tuulikki Sokka, Bharathi Lingala, Bonnie Bruce, Matthias Rose, Eliza F. Chakravarty and Pekka Hannonen. Their work appears in journals such as Arthritis Research & Therapy, The Journal of Rheumatology, Annals of the Rheumatic Diseases, Lara D. Veeken and The American Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact